110464-40-9

Upstream product

• 1030268-24-6 trimethylsulphoxonium iodide 
• 101411-57-8 4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-2-<(2-oxopropoxy)methyl>-1,4-dihydropyridine 
• 101411-65-8 1-<<4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridin-2-yl>methoxy>-2-propyne 
• 90445-15-1 2-{[4-(2,3-dichlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridin-2-yl]methoxy}acetic acid 

Downstream Products

• 110464-23-8 4-(2,3-Dichloro-phenyl)-2-(2-hydroxy-3-imidazol-1-yl-2-methyl-propoxymethyl)-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester 
• 110476-90-9 1-{[4-(2,3-Dichlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyrid-2-]methoxy}-2-hydroxy-2-methyl-3-(1,2,4-triazol-1-yl)propane 
• 110464-29-4 4-(2,3-Dichloro-phenyl)-2-[2-hydroxy-2-methyl-3-(pyrimidin-2-ylamino)-propoxymethyl]-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester 
• 110464-35-2 1-{[4-(2,3-Dichlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyrid-2-yl]methoxy}-2,3-dihydroxy-2-methylpropane 
• 110464-25-0 2-<(3-azido-2-hydroxy-2-methylpropoxy)methyl>-4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine 
• 110464-36-3 1-amino-3-{[4-(2,3-dichlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyrid-2-yl]methoxy}-2-hydroxy-2-methylpropane 
• 110464-28-3 4-(2,3-Dichloro-phenyl)-2-[2-hydroxy-2-methyl-3-(pyrimidin-2-ylsulfanyl)-propoxymethyl]-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester 

Relevant academic research and scientific papers

Long-acting dihydropyridine calcium antagonists. 6. Structure-activity relationships around 4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-2-[(2-hydroxyethoxy) methyl]-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine

The preparation of 4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-2-[(2-hydroxyethoxy) methyl]-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyrimidine (2) is described, and its potent calcium antagonist activity on rat aorta (IC50 = 4 x 10-9 M

2-oxygen containing heteroalkoxyalkyl dihydropyridine intermediates

1,4-Dihydropyridine anti-ischaemic and antihypertensive agent of the formula: STR1 or a pharmaceutically acceptable salt thereof, wherein R is 2-chlorophenyl, 2,3-dichlorophenyl or 2-chloro-3-trifluoromethylphenyl; R1 and R2 are each